Vanguard Group Inc Greenwich Life Sciences, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 269,002 shares of GLSI stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
269,002
Previous 270,306 0.48%
Holding current value
$2.65 Million
Previous $2.58 Million 5.39%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$8.76 - $10.44 $11,423 - $13,613
-1,304 Reduced 0.48%
269,002 $2.44 Million
Q1 2025

May 09, 2025
SELL
$9.54 - $13.43 $44,694 - $62,919
-4,685 Reduced 1.7%
270,306 $2.58 Million
Q4 2024

Feb 11, 2025
BUY
$10.91 - $14.95 $15,994 - $21,916
1,466 Added 0.54%
274,991 $3.09 Million
Q3 2024

Nov 13, 2024
BUY
$12.99 - $17.58 $69,587 - $94,176
5,357 Added 2.0%
273,525 $3.93 Million
Q2 2024

Aug 13, 2024
BUY
$12.07 - $19.04 $543,946 - $858,056
45,066 Added 20.2%
268,168 $4.63 Million
Q1 2024

May 10, 2024
BUY
$8.31 - $20.32 $11,800 - $28,854
1,420 Added 0.64%
223,102 $4.45 Million
Q4 2023

Feb 14, 2024
BUY
$7.77 - $12.3 $13,434 - $21,266
1,729 Added 0.79%
221,682 $2.33 Million
Q3 2023

Nov 14, 2023
SELL
$8.41 - $10.66 $523,623 - $663,712
-62,262 Reduced 22.06%
219,953 $1.94 Million
Q2 2023

Aug 14, 2023
SELL
$9.58 - $13.2 $671,644 - $925,438
-70,109 Reduced 19.9%
282,215 $2.72 Million
Q1 2023

May 15, 2023
BUY
$12.12 - $20.8 $94,536 - $162,240
7,800 Added 2.26%
352,324 $4.86 Million
Q4 2022

Feb 10, 2023
BUY
$9.04 - $16.88 $795 - $1,485
88 Added 0.03%
344,524 $5.24 Million
Q3 2022

Nov 14, 2022
SELL
$7.81 - $12.02 $76,538 - $117,796
-9,800 Reduced 2.77%
344,436 $3.13 Million
Q2 2022

Aug 12, 2022
SELL
$7.14 - $20.36 $149,682 - $426,827
-20,964 Reduced 5.59%
354,236 $3 Million
Q1 2022

May 13, 2022
BUY
$16.3 - $24.65 $3.67 Million - $5.55 Million
225,213 Added 150.16%
375,200 $7.36 Million
Q4 2021

Feb 14, 2022
BUY
$21.76 - $39.43 $15,079 - $27,324
693 Added 0.46%
149,987 $3.65 Million
Q3 2021

Nov 12, 2021
BUY
$38.65 - $46.11 $1.08 Million - $1.29 Million
27,876 Added 22.96%
149,294 $5.83 Million
Q2 2021

Aug 13, 2021
BUY
$31.24 - $53.6 $3.79 Million - $6.51 Million
121,418 New
121,418 $5.46 Million

Others Institutions Holding GLSI

# of Institutions
49
Shares Held
1.24M
Call Options Held
0
Put Options Held
0
View Full List

About Greenwich LifeSciences, Inc.

GLSI Quotes by TradingView
  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $127M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email